Home > Insider Trading > Filing (0000899243-15-009575)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021944	Ltd (Private) Holdings Temasek	60B Orchard Road #06-18, Tower 2 The Atrium@Orchard Singapore U0 238891		No	No	Yes	No
1379348	Ltd Pte Management Fullerton	60B Orchard Road #06-18, Tower 2 The Atrium@Orchard Singapore U0 238891		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-09	750,000	$48.00	6,583,568	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

Fullerton Management Pte Ltd ("FMPL") indirectly owns 6,583,568 shares of the Issuer's common stock ("Shares") through two indirect wholly-owned subsidiaries, V-Sciences Investments Pte Ltd ("V-Sciences") which owns 750,000 Shares and Maxwell (Mauritius) Pte Ltd ("Maxwell") which owns 5,833,568 Shares. V-Sciences is wholly-owned by Temasek Life Sciences Private Limited, which is wholly owned by FMPL. Maxwell is wholly-owned by Cairnhill Investments (Mauritius) Pte Ltd which is wholly owned by FMPL. FMPL is wholly-owned by Temasek Holdings (Private) Limited. Accordingly, each of FMPL and Temasek Holdings (Private) Limited, through the ownership described herein, may be deemed to beneficially own the shares of common stock owned by V-Sciences and Maxwell, collectively.